Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

$60 USD share price for AGN/PF?

That shakes out to approx $6 Billion USD market cap

Mid-cap stocks are shares of public companies with market capitalizations between $1 billion and $5 billion. Some analysts even consider companies as large as $10 billion to be mid-cap. The market cap is the company's number of shares times the stock price. These are familiar companies that have good growth potential

Here's a snapshot of Algernon's target market:

#1. Johnson & Johnson. $372.2 billion.
#2. Roche. $239.6 billion.
#3. Pfizer. $235.8 billion.
#4. Novartis. $226.3 billion.
#5. Merck. $213.3 billion.
#6. Eli Lilly. $133.6 billion.
#7. Novo Nordisk.
#8. AbbVie. $119.1 billion.
#9. Amgen. $116.8 billion.
#10. Sanofi. $115.7 billion.
#11. GlaxoSmithKline. $105.7 billion.
#12. AstraZeneca. $103.7 billion.
#13. Gilead Sciences. $81.2 billion.
#14. Bristol-Myers Squibb. $78.1 billion.
#15. CSL. $65.9 billion.
#16. Takeda Pharmaceuticals. $53.4 billion.
#17. Bayer. $63.4 billion.
#18. Celgene. $61.4 billion.
#19. Merck KGaA. $52.2 billion.
#20. Allergan. $48.7 billion.

I assure you there is a long list after that that reaches down to $6 billion USD market cap.

None of the currently have an FDA "approved" treatment for COVID-19.

If and when there is an approved treatment - Algernon still retains it's ability to capture a global market share.

One drug will not be the only option for the entire planet.

Do I think your 6 Billion USD (or is that CAD?) target for Algernon is reasonable?

Who know?

The entire world is in panic mode.

The sky is the limit and a bidding war between Big Pharma coupled to shareholder speculation/frenzy could friggin run the stock to $100 USD.

However, I'm more than happy to ride a rocket to a market cap of 1 to 2 Billion USD.

That, I believe is attainable with either clinical trial for idiopathic pulmonary fibrosis, chronic cough, or COVID-19.

Hitting the Trifecta...Yeah I'll take the 6 Billion USD market cap All Day!

If you truly listen to/absorb the BioPub video in the sticky notes, management talks about another repuposed drug bought out for $1.7 Billion USD.

It's not pie in the sky stuff going on at Algernon.

Sometimes it just requires one to THINK BIG.

How about we save any lingering questions on this matter for a rainy day?



/////AMG